Skip to main content
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.99
+0.03 (0.36%)
Mar 9, 2026, 2:53 PM EDT - Market open

Lifecore Biomedical Revenue

In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $31.11M in the quarter ending September 30, 2025, with 25.92% growth.

Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
1.98
Revenue / Employee
$317,406
Employees
406
Market Cap
261.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 25, 2025128.87M606.00K0.47%
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020 Pro Pro Pro
May 26, 2019 Pro Pro Pro
May 27, 2018 Pro Pro Pro
May 28, 2017 Pro Pro Pro
May 29, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 742.90M
Organogenesis Holdings 564.17M
Evolus 297.18M
Aurora Cannabis 272.13M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Canopy Growth 203.04M
SIGA Technologies 172.25M
Revenue Rankings

LFCR News

More News